MediVax
Paris, France· Est.
MediVax is a French biotechnology company developing novel vaccine platforms and immunotherapies for infectious diseases and cancer.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $115M
About
MediVax is a French biotechnology company developing novel vaccine platforms and immunotherapies for infectious diseases and cancer.
VaccinesInfectious DiseaseOncology
Funding History
1Total raised:$115M
Series D$115M